Literature DB >> 2217772

Cervical lymph node metastasis: assessment of radiologic criteria.

M W van den Brekel1, H V Stel, J A Castelijns, J J Nauta, I van der Waal, J Valk, C J Meyer, G B Snow.   

Abstract

To estimate the accuracy of different radiologic criteria used to detect cervical lymph node metastasis in patients with head and neck carcinoma, seven different characteristics of 2,719 lymph nodes in 71 neck dissection specimens from 55 patients were assessed. Three lymph node diameters, their location, their number, the presence of a tumor, and the amount of necrosis and fatty metaplasia were recorded. The minimal diameter in the axial plane was found to be the most accurate size criterion for predicting lymph node metastasis. A minimal axial diameter of 10 mm was determined to be the most effective size criterion. The size criterion for lymph nodes in the subdigastric region was 1 mm larger (11 mm). Groups of three or more borderline nodes were proved to increase the sensitivity but did not significantly decrease the specificity. Radiologically detectable necrosis (3 mm or larger) was found only in tumorous nodes and was present in 74% of the positive neck dissection specimens. Shape was not a valuable criterion for the radiologic assessment of the cervical lymph node status.

Entities:  

Mesh:

Year:  1990        PMID: 2217772     DOI: 10.1148/radiology.177.2.2217772

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  190 in total

1.  Detection of lymph node metastases in the neck: radiologic criteria.

Authors:  J A Castelijns; M W van den Brekel
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

Review 2.  Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  Sarah J Vinnicombe; Rodney H Reznek
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-23       Impact factor: 9.236

Review 3.  Parapharyngeal ectopic thyroid: the possible persistence of the lateral thyroid anlage. Clinical case report.

Authors:  A Soscia; G Guerra; M-P Cinelli; D Testa; V Galli; V Macchi; R De Caro
Journal:  Surg Radiol Anat       Date:  2004-05-08       Impact factor: 1.246

4.  Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response.

Authors:  Ann D King; Frankie K F Mo; Kwok-Hung Yu; David K W Yeung; Hua Zhou; Kunwar S Bhatia; Gary M K Tse; Alexander C Vlantis; Jeffrey K T Wong; Anil T Ahuja
Journal:  Eur Radiol       Date:  2010-03-23       Impact factor: 5.315

5.  [Sonographic differential diagnosis of cervical masses].

Authors:  P Jecker
Journal:  HNO       Date:  2011-02       Impact factor: 1.284

6.  Magnetic resonance imaging staging of nasopharyngeal carcinoma in the head and neck.

Authors:  Ann Dorothy King; Kunwar Suryaveer Singh Bhatia
Journal:  World J Radiol       Date:  2010-05-28

7.  Combined multimodal co-registration of PET/CT and MRI images increases diagnostic accuracy in squamous cell carcinoma staging.

Authors:  Alessandro Stecco; Silvio Ciolfi; Francesco Buemi; Alessia Cassarà; Gian Mauro Sacchetti; Marco Brambilla; Alessandro Carriero
Journal:  Radiol Med       Date:  2016-01-11       Impact factor: 3.469

8.  [18F]FDG PET/MRI versus contrast-enhanced MRI in detecting regional HNSCC metastases.

Authors:  Filippo Crimì; Daniele Borsetto; Roberto Stramare; Roberto Di Carlo; Enzo Emauelli; Piero Nicolai; Carmelo Lacognata; Pietro Zucchetta; Giulia Oliveri; Arcangelo Merola; Valentina Bodanza; Laura Albertoni; Cristina Campi; Diego Cecchin
Journal:  Ann Nucl Med       Date:  2021-01-17       Impact factor: 2.668

9.  Modification of staging and treatment of head and neck cancer by FDG-PET/CT prior to radiotherapy.

Authors:  A Abramyuk; S Appold; K Zöphel; M Baumann; N Abolmaali
Journal:  Strahlenther Onkol       Date:  2013-01-19       Impact factor: 3.621

10.  [18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methods.

Authors:  S Dresel; J Grammerstorff; K Schwenzer; K Brinkbäumer; R Schmid; T Pfluger; K Hahn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-09       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.